📣 VC round data is live. Check it out!
- Public Comps
- Balsm Alofoq
Balsm Alofoq Valuation Multiples
Discover revenue and EBITDA valuation multiples for Balsm Alofoq and similar public comparables like Farmaceutica Remedia, Ortivus, iZafe Group, Etropal and more.
Balsm Alofoq Overview
About Balsm Alofoq
Balsm Alofoq Medical Co operates in the medical sector. Its activities include medical services, specialized clinics and medical complexes, medical operations, and the import and supply of medical devices and supplies to all regions of the Kingdom of Saudi Arabia.
Founded
2012
HQ

Employees
N/A
Website
Sectors
Financials (FY)
EV
$13M
Valuation Multiples
Start free trialBalsm Alofoq Financials
Balsm Alofoq reported last fiscal year revenue of $6M and EBITDA of $1M.
In the same fiscal year, Balsm Alofoq generated $2M in gross profit, $1M in EBITDA, and $535K in net income.
Balsm Alofoq P&L
In the most recent fiscal year, Balsm Alofoq reported revenue of $6M and EBITDA of $1M.
Balsm Alofoq is profitable as of last fiscal year, with gross margin of 38%, EBITDA margin of 19%, and net margin of 10%.
Financial data powered by Morningstar, Inc.
Balsm Alofoq Stock Performance
Balsm Alofoq has current market cap of $15M, and enterprise value of $13M.
Market Cap Evolution
Balsm Alofoq's stock price is $6.18.
Balsm Alofoq share price increased by 1.6% in the last 30 days, and decreased by 39.0% in the last year.
Balsm Alofoq has an EPS (earnings per share) of $0.21.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13M | $15M | 2.0% | 1.6% | -17.0% | -39.0% | $0.21 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBalsm Alofoq Valuation Multiples
Balsm Alofoq trades at 2.3x EV/Revenue multiple, and 12.6x EV/EBITDA.
Balsm Alofoq Financial Valuation Multiples
As of May 26, 2026, Balsm Alofoq has market cap of $15M and EV of $13M.
Balsm Alofoq has a P/E ratio of 28.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Balsm Alofoq Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Balsm Alofoq Margins & Growth Rates
In the most recent fiscal year, Balsm Alofoq reported gross margin of 38%, EBITDA margin of 19%, and net margin of 10%.
Balsm Alofoq Margins
Balsm Alofoq Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Balsm Alofoq Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Balsm Alofoq Competitors
Balsm Alofoq competitors include Farmaceutica Remedia, Ortivus, iZafe Group, Etropal, Jin Medical International, BPC Instruments, Prolight Diagnostics, Airway Medix, BioRegenx and Cuprina Holdings (Cayman).
Most Balsm Alofoq public comparables operate across Medical Supplies.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.0x | — | 1.0x | — | |||
| 2.4x | — | (12.2x) | — | |||
| 26.9x | — | (14.3x) | — | |||
| 1.4x | — | 17.9x | — | |||
| 0.4x | — | 8.2x | — | |||
| 1.7x | — | 7.7x | — | |||
| — | — | (4.4x) | — | |||
| 11589.3x | — | 13.3x | — | |||
This data is available for Pro users. Sign up to see all Balsm Alofoq competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Balsm Alofoq
| When was Balsm Alofoq founded? | Balsm Alofoq was founded in 2012. |
| Where is Balsm Alofoq headquartered? | Balsm Alofoq is headquartered in Saudi Arabia. |
| Is Balsm Alofoq publicly listed? | Yes, Balsm Alofoq is a public company listed on Tadawul. |
| What is the stock symbol of Balsm Alofoq? | Balsm Alofoq trades under 9620 ticker. |
| When did Balsm Alofoq go public? | Balsm Alofoq went public in 2024. |
| Who are competitors of Balsm Alofoq? | Balsm Alofoq main competitors include Farmaceutica Remedia, Ortivus, iZafe Group, Etropal, Jin Medical International, BPC Instruments, Prolight Diagnostics, Airway Medix, BioRegenx, Cuprina Holdings (Cayman). |
| What is the current market cap of Balsm Alofoq? | Balsm Alofoq's current market cap is $15M. |
| What is the current revenue of Balsm Alofoq? | Balsm Alofoq's last fiscal year revenue is $6M. |
| What is the current EV/Revenue multiple of Balsm Alofoq? | Current revenue multiple of Balsm Alofoq is 2.3x. |
| Is Balsm Alofoq profitable? | No, Balsm Alofoq is not profitable. |
| How many companies Balsm Alofoq has acquired to date? | Balsm Alofoq hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Balsm Alofoq has invested to date? | Balsm Alofoq hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Balsm Alofoq
Lists including Balsm Alofoq
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.